Literature DB >> 28850772

Mesenchymal stromal cell engagement in cancer cell epithelial to mesenchymal transition.

Drenka Trivanović1, Jelena Krstić1, Aleksandra Jauković1, Diana Bugarski1, Juan F Santibanez2.   

Abstract

Due to coexistence of stromal and epithelial tumor cells, their dynamic interactions have been widely recognized as significant cellular components to the tumor tissue integrity. Initiation and outcome of epithelial to mesenchymal transition (EMT) in tumor cells are dependent on their interaction with adjacent or recruited mesenchymal stromal cells (MSCs). A plethora of mechanisms are involved in MSCs-controlled employment of the developmental processes of EMT that contribute to loss of epithelial cell phenotype and acquisition of stemness, invasiveness and chemoresistance of tumor cells. Interplay of MSCs with tumor cells, including interchange of soluble biomolecules, plasma membrane structures, cytoplasmic content, and organelles, is established through cell-cell contact and/or by means of paracrine signaling. The main focus of this review is to summarize knowledge about involvement of MSCs in cancer cell EMT. Understanding the underlying cellular and molecular mechanism involved in the interplay between MSCs and cancer EMT is essential for development of effective therapy approaches, which in combination with current treatments may improve the control of tumor progression. Developmental Dynamics 247:359-367, 2018.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; epithelial to mesenchymal transition; mesenchymal stromal cells; stem cells

Mesh:

Year:  2017        PMID: 28850772     DOI: 10.1002/dvdy.24583

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  6 in total

1.  Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients.

Authors:  Raheleh Roudi; Mahboubeh Barodabi; Zahra Madjd; Giandomenico Roviello; Silvia Paola Corona; Mahshid Panahei
Journal:  Mol Cell Oncol       Date:  2020-07-14

2.  The Secretome of Human Neonatal Mesenchymal Stem Cells Modulates Doxorubicin-Induced Cytotoxicity: Impact in Non-Tumor Cells.

Authors:  Ana S Serras; Sérgio P Camões; Bernardo Antunes; Vera M Costa; Flávio Dionísio; Volkan Yazar; Rui Vitorino; Fernando Remião; Matilde Castro; Nuno G Oliveira; Joana P Miranda
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

3.  An in-silico study of cancer cell survival and spatial distribution within a 3D microenvironment.

Authors:  Marilisa Cortesi; Chiara Liverani; Laura Mercatali; Toni Ibrahim; Emanuele Giordano
Journal:  Sci Rep       Date:  2020-07-31       Impact factor: 4.379

Review 4.  Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Epithelial-Mesenchymal Transition.

Authors:  Sevindzh Kletukhina; Olga Neustroeva; Victoria James; Albert Rizvanov; Marina Gomzikova
Journal:  Int J Mol Sci       Date:  2019-09-27       Impact factor: 5.923

5.  Mesenchymal stem cells promote metastasis through activation of an ABL-MMP9 signaling axis in lung cancer cells.

Authors:  Jing Jin Gu; Jacob Hoj; Clay Rouse; Ann Marie Pendergast
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

6.  Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma.

Authors:  Qiusheng Shan; Kiyofumi Takabatake; Haruka Omori; Hotaka Kawai; May Wathone Oo; Keisuke Nakano; Soichiro Ibaragi; Akira Sasaki; Hitoshi Nagatsuka
Journal:  Int J Oncol       Date:  2021-08-09       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.